140 related articles for article (PubMed ID: 32592133)
1. Efficient photodynamic therapy against drug-resistant prostate cancer using replication-deficient virus particles and talaporfin sodium.
Akter S; Saito S; Inai M; Honda N; Hazama H; Nishikawa T; Kaneda Y; Awazu K
Lasers Med Sci; 2021 Jun; 36(4):743-750. PubMed ID: 32592133
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy by lysosomal-targeted drug delivery using talaporfin sodium incorporated into inactivated virus particles.
Akter S; Inai M; Saito S; Honda N; Hazama H; Nishikawa T; Kaneda Y; Awazu K
Laser Ther; 2019 Dec; 28(4):245-256. PubMed ID: 32255916
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy using a cytotoxic photosensitizer porphyrus envelope that targets the cell membrane.
Inai M; Honda N; Hazama H; Akter S; Fuse S; Nakamura H; Nishikawa T; Kaneda Y; Awazu K
Photodiagnosis Photodyn Ther; 2017 Dec; 20():238-245. PubMed ID: 29079353
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of a new photosensitizer for photodynamic therapy of early head and neck cancer in relation to tissue concentration.
Yoshida T; Tokashiki R; Ito H; Shimizu A; Nakamura K; Hiramatsu H; Tsukahara K; Shimizu S; Takata D; Okamoto I; Suzuki M
Auris Nasus Larynx; 2008 Dec; 35(4):545-51. PubMed ID: 18242905
[TBL] [Abstract][Full Text] [Related]
5. A novel photodynamic therapy for drug-resistant prostate cancer cells using porphyrus envelope as a novel photosensitizer.
Yamauchi M; Honda N; Hazama H; Tachikawa S; Nakamura H; Kaneda Y; Awazu K
Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):48-54. PubMed ID: 24629697
[TBL] [Abstract][Full Text] [Related]
6. Development of a practical animal model of photodynamic therapy using a high concentration of extracellular talaporfin sodium in interstitial fluid: influence of albumin animal species on myocardial cell photocytotoxicity in vitro.
Ogawa E; Arai T
Lasers Med Sci; 2017 Dec; 32(9):2105-2109. PubMed ID: 28980086
[TBL] [Abstract][Full Text] [Related]
7. In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope.
Sakai M; Fujimoto N; Ishii K; Nakamura H; Kaneda Y; Awazu K
J Biomed Opt; 2012 Jul; 17(7):77009. PubMed ID: 23085849
[TBL] [Abstract][Full Text] [Related]
8. TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles.
Matsushima-Miyagi T; Hatano K; Nomura M; Li-Wen L; Nishikawa T; Saga K; Shimbo T; Kaneda Y
Clin Cancer Res; 2012 Nov; 18(22):6271-83. PubMed ID: 23014529
[TBL] [Abstract][Full Text] [Related]
9. In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope.
Sakai M; Fujimoto N; Ishii K; Nakamura H; Kaneda Y; Awazu K
J Biomed Opt; 2012 Jul; 17(7):077009. PubMed ID: 23066541
[TBL] [Abstract][Full Text] [Related]
10. Tissue damage in the canine normal esophagus by photoactivation with talaporfin sodium (laserphyrin): a preclinical study.
Horimatsu T; Muto M; Yoda Y; Yano T; Ezoe Y; Miyamoto S; Chiba T
PLoS One; 2012; 7(6):e38308. PubMed ID: 22719875
[TBL] [Abstract][Full Text] [Related]
11. Synergic effect of photodynamic therapy using talaporfin sodium with conventional anticancer chemotherapy for the treatment of bile duct carcinoma.
Nonaka Y; Nanashima A; Nonaka T; Uehara M; Isomoto H; Abo T; Nagayasu T
J Surg Res; 2013 May; 181(2):234-41. PubMed ID: 22835954
[TBL] [Abstract][Full Text] [Related]
12. A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer.
Yano T; Kasai H; Horimatsu T; Yoshimura K; Teramukai S; Morita S; Tada H; Yamamoto Y; Kataoka H; Kakushima N; Ishihara R; Isomoto H; Muto M
Oncotarget; 2017 Mar; 8(13):22135-22144. PubMed ID: 28212527
[TBL] [Abstract][Full Text] [Related]
13. Two cases of bile duct carcinoma patients who underwent the photodynamic therapy using talaporfin sodium (Laserphyrin
Nanashima A; Hiyoshi M; Imamura N; Hamada T; Nishida T; Kawakami H; Ban T; Kubota Y; Nakashima K; Yano K; Wada T; Takeno S; Kai M
Clin J Gastroenterol; 2020 Feb; 13(1):102-109. PubMed ID: 31222455
[TBL] [Abstract][Full Text] [Related]
14. Detailed in vitro study of the photosensitization reaction of extracellular Talaporfin sodium in rat myocardial cells.
Ogawa E; Ito A; Arai T
Lasers Surg Med; 2013 Dec; 45(10):660-7. PubMed ID: 24339254
[TBL] [Abstract][Full Text] [Related]
15. Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle.
Kawaguchi Y; Miyamoto Y; Inoue T; Kaneda Y
Int J Cancer; 2009 May; 124(10):2478-87. PubMed ID: 19173282
[TBL] [Abstract][Full Text] [Related]
16. [Development of a novel photosensitizer, talaporfin sodium, for the photodynamic therapy (PDT)].
Tsukagoshi S;
Gan To Kagaku Ryoho; 2004 Jun; 31(6):979-85. PubMed ID: 15222124
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy using talaporfin sodium (Laserphyrin®) for bile duct carcinoma: a preliminary clinical trial.
Nanashima A; Abo T; Nonaka T; Nonaka Y; Morisaki T; Uehara R; Ohnita K; Fukuda D; Murakami G; Tou K; Kunizaki M; Hidaka S; Tsuchiya T; Takeshita H; Nakao K; Nagayasu T
Anticancer Res; 2012 Nov; 32(11):4931-8. PubMed ID: 23155262
[TBL] [Abstract][Full Text] [Related]
18. Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors.
Muragaki Y; Akimoto J; Maruyama T; Iseki H; Ikuta S; Nitta M; Maebayashi K; Saito T; Okada Y; Kaneko S; Matsumura A; Kuroiwa T; Karasawa K; Nakazato Y; Kayama T
J Neurosurg; 2013 Oct; 119(4):845-52. PubMed ID: 23952800
[TBL] [Abstract][Full Text] [Related]
19. In vitro behavior of Porfimer sodium and Talaporfin sodium with high intensity pulsed irradiation.
Ohmori S; Arai T
Lasers Med Sci; 2006 Dec; 21(4):213-23. PubMed ID: 17024319
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer.
Yano T; Muto M; Yoshimura K; Niimi M; Ezoe Y; Yoda Y; Yamamoto Y; Nishisaki H; Higashino K; Iishi H
Radiat Oncol; 2012 Jul; 7():113. PubMed ID: 22824179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
